Quaternary structures of Vac8 differentially regulate the Cvt and PMN pathways. by Park, Jumi et al.
Full Terms & Conditions of access and use can be found at
https://www.tandfonline.com/action/journalInformation?journalCode=kaup20
Autophagy
ISSN: 1554-8627 (Print) 1554-8635 (Online) Journal homepage: https://www.tandfonline.com/loi/kaup20
Quaternary structures of Vac8 differentially
regulate the Cvt and PMN pathways
Jumi Park, Hye-In Kim, Hanbin Jeong, Miriam Lee, Se Hwan Jang, So Young
Yoon, Hyejin Kim, Zee-Yong Park, Youngsoo Jun & Changwook Lee
To cite this article: Jumi Park, Hye-In Kim, Hanbin Jeong, Miriam Lee, Se Hwan Jang, So
Young Yoon, Hyejin Kim, Zee-Yong Park, Youngsoo Jun & Changwook Lee (2019): Quaternary
structures of Vac8 differentially regulate the Cvt and PMN pathways, Autophagy, DOI:
10.1080/15548627.2019.1659615
To link to this article:  https://doi.org/10.1080/15548627.2019.1659615
© 2019 The Author(s). Published by Informa
UK Limited, trading as Taylor & Francis
Group.
View supplementary material 
Published online: 12 Sep 2019.
Submit your article to this journal 
View related articles 
View Crossmark data
RESEARCH PAPER
Quaternary structures of Vac8 differentially regulate the Cvt and PMN pathways
Jumi Park a,b*, Hye-In Kimb,c*, Hanbin Jeong a,b, Miriam Leeb,c, Se Hwan Jangc, So Young Yoonb,c, Hyejin Kima,b,
Zee-Yong Parkc, Youngsoo Junb,c, and Changwook Lee a,b
aDepartment of Biological Sciences, School of Life Sciences, Ulsan National Institute of Science and Technology, Ulsan, Republic of Korea; bCell
Logistics Research Center, Gwangju Institute of Science and Technology, Gwangju, Republic of Korea; cSchool of Life Sciences, Gwangju Institute of
Science and Technology, Gwangju, Republic of Korea
ABSTRACT
Armadillo (ARM) repeat proteins constitute a large protein family with diverse and fundamental func-
tions in all organisms, and armadillo repeat domains share high structural similarity. However, exactly
how these structurally similar proteins can mediate diverse functions remains a long-standing question.
Vac8 (vacuole related 8) is a multifunctional protein that plays pivotal roles in various autophagic
pathways, including piecemeal microautophagy of the nucleus (PMN) and cytoplasm-to-vacuole target-
ing (Cvt) pathways in the budding yeast Saccharomyces cerevisiae. Vac8 comprises an H1 helix at the
N terminus, followed by 12 armadillo repeats. Herein, we report the crystal structure of Vac8 bound to
Atg13, a key component of autophagic machinery. The 70-Å extended loop of Atg13 binds to the ARM
domain of Vac8 in an antiparallel manner. Structural, biochemical, and in vivo experiments demon-
strated that the H1 helix of Vac8 intramolecularly associates with the first ARM and regulates its self-
association, which is crucial for Cvt and PMN pathways. The structure of H1 helix-deleted Vac8
complexed with Atg13 reveals that Vac8[Δ19–33]-Atg13 forms a heterotetramer and adopts an
extended superhelical structure exclusively employed in the Cvt pathway. Most importantly, comparison
of Vac8-Nvj1 and Vac8-Atg13 provides a molecular understanding of how a single ARM domain protein
adopts different quaternary structures depending on its associated proteins to differentially regulate 2
closely related but distinct cellular pathways.
Abbreviations : Ape1: aminopeptidase I; ARM: armadillo repeat; Atg: autophagy-related; AUC: analytical
ultracentrifugation; Cvt: cytoplasm-to-vacuole targeting; DIC: differential interference contrast; GFP:
green fluorescent protein; GST: glutathione-S-transferase; ITC: isothermal titration calorimetry; NVJ:
nucleus-vacuole junction; PDB: protein data bank; PMN: piecemeal microautophagy of the nucleus;
prApe1: precursor Ape1; RMSD: root-mean-square deviation; SAXS: small-angle X-ray scattering; SD-N:
nitrogen starvation medium; SEC: size-exclusion chromatography; tAtg13: Atg13 construct comprising
residues 567–695; tNvj1: Nvj1 construct comprising residues 229–321; tVac8: Vac8 construct comprising
residues 10–515; Vac8: vacuole related 8
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Introduction
Yeast vacuoles, the equivalent of mammalian lysosomes, are
membrane-bound organelles that serve a variety of pivotal
functions including storage and digestion of waste products,
regulation of cellular pH, and autophagy [1–7]. Vacuoles
undergo constant fusion and fission that determines their
inheritance during mitosis [8–10], and genetic screens of
defects in vacuole inheritance have identified several genes
specifically involved in the process [9,11–13], including Vac8
(vacuole related 8), a protein with armadillo repeats (ARMs)
[14,15]. Vac8 binds to Myo2 (myosin 2) via the scaffold
protein Vac17, and this ternary protein complex mediates
vacuole migration toward the growing bud during cell divi-
sion [16]. Vac8 is composed of ARMs, and myristoylation and
palmitoylation lipid modification sites at the N-terminal
region that anchor it into vacuolar membranes [14,15,17].
Consequently, the ARM domain is exclusively localized in
the cytoplasm, where it is involved in the formation of mem-
brane contact sites by acting as a scaffold to interact with
various proteins from other organelles [14,15].
Vac8 also plays an important role in
piecemeal microautophagy of the nucleus (PMN) [18–20],
during which a portion of the nucleus is transported to and
degraded in the vacuole during nutrition starvation. PMN
occurs at the nucleus-vacuole junction (NVJ), a well-
characterized membrane contact site [18–20]. Vac8
anchored in vacuolar membranes directly associates with
the outer nuclear membrane protein Nvj1, and physical
interaction between Vac8 and Nvj1 mediates the formation
of nucleus-vacuole membrane contact sites [21], thereby
promoting PMN [18–20]. In addition, a recent study
CONTACT Youngsoo Jun junys@gist.ac.kr School of Life Sciences and Cell Logistics Research Center, Gwangju Institute of Science and Technology (GIST),
Gwangju 61005, Republic of Korea; Changwook Lee changwook@unist.ac.kr Department of Biological Sciences, School of Life Sciences, Ulsan National
Institute of Science and Technology (UNIST), 50 UNIST-gil, Ulsan 44919, Republic of Korea
*These authors contributed equally to this work.
Supplementary material for this article can be accessed here.
AUTOPHAGY
https://doi.org/10.1080/15548627.2019.1659615
© 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License (http://creativecommons.org/licenses/by-nc-nd/4.0/),
which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited, and is not altered, transformed, or built upon in any way.
revealed that Vac8 forms a complex with Lam6/Ltc1 (lipid
transfer protein anchored at membrane contact site 6) at
ER-vacuole contact sites and mediates sterol transport to
generate sterol-enriched vacuolar membrane domains [22].
Furthermore, Vac8 is involved in the cytoplasm-to-vacuole
targeting (Cvt) pathway, which transports cytoplasmic pro-
teins to the vacuolar lumen in a manner similar to selective
autophagy [15]. Upon nutrient starvation, Vac8 interacts with
the key autophagy protein Atg13 (autophagy-related 13), and
the resulting complex delivers cytoplasmic hydrolases such as
Ape1 (aminopeptidase I) to the vacuole, where they become
activated and functional [23]. Ape1 is synthesized as
a precursor (prApe1) in the cytosol and transferred into the
vacuole lumen through Cvt vesicles [15,23]. While much has
been learned about the Vac8-Atg13 complex and its involve-
ment in the Cvt pathway, the molecular mechanism by which
Atg13 is specifically recognized by Vac8 remains elusive. In
addition, our previous study suggested that Nvj1 shares
a binding interface for Vac8 with Atg13; therefore, Nvj1 or
Atg13 competes for binding to Vac8 [24]. However, it is still
unknown how Vac8 can discriminate between Nvj1 or Atg13,
and thereby differentially regulate PMN or Cvt pathways that
occur simultaneously in yeast.
In the present study, we present 2 crystal structures of
Atg13 bound to Vac8. These structures, along with biochem-
ical and in vivo experiments, reveal that Atg13 binding may
induce the self-association of Vac8 by regulating the H1 helix,
and the resulting Vac8-Atg13 heterotetramer adopts a super-
helical structure. Furthermore, we demonstrate that the qua-
ternary structural organization of Vac8 caused by binding of
Atg13 or Nvj1 selectively supports Cvt or PMN pathways,
respectively.
Results
Structure of tVac8 in complex with tAtg13
The Saccharomyces cerevisiae Atg13 protein is composed of 738
residues (Figure 1A). The sequences from the N terminus to
residue 521 are well conserved among mammalian ATG13
orthologs, and required for interaction with essential compo-
nents of the autophagy machinery, including Atg1, Atg17, and
Atg9 [25–27]. By contrast, the remaining residues from 522 to
the end of the C terminus are present only in the yeast Atg13
protein. A previous yeast two-hybrid analysis and co-
immunoprecipitation experiments revealed that the C-terminal
region of Atg13 comprising residues 567–692 is required for
association with Vac8 [23]. Based on these data, we made
a truncated Atg13 construct (residues 567–695; designated as
tAtg13) for structural analysis of the tVac8-tAtg13 complex.
tVac8 (residues 10–515) was used in our previous study
(Figure 1A) [24]. Analytical ultracentrifugation (AUC) experi-
ment revealed that the tVac8-tAtg13 complex formed
a heterodimer in solution (Figure 1B). Crystals of tVac8-tAtg13
were grown in a reservoir buffer containing polyethylene glycol
(PEG) 400 as the main precipitant, and the structure was solved
by the molecular replacement method using the Vac8 coordi-
nates (PDB code: 5XJG) as a search model and refined to 2.9 Å
resolution (Table S2).
Figure 1C shows the overall structure of tVac8 complexed
with tAtg13 in ribbon representation. In our previous study, we
revealed that tVac8 is composed of an H1 helix (residues 19–33)
at the N terminus, followed by 12 central armadillo repeats
(ARMs; Figure 1D) [24]. The loop (residues 35–40) bridging
the H1 helix and the first ARM (ARM1) is disordered in the
structure (Figure 1D). The overall conformation of the 12 con-
certed ARMs of tVac8 observed in the crystal structure of the
tVac8-tAtg13 complex was essentially identical to that observed
in the tVac8-tNvj1 complex [24], with a root-mean-square
deviation (RMSD) value of 0.88 Å for all Cα atoms. The 70-Å
extended loop of Atg13 binds across the inner groove formed by
the central ARMs of Vac8 (Figure 1C). Similar to the tVac8-
tNvj1 complex, Atg13 binds to Vac8 in an antiparallel fashion
(Figure 1C,D). Electron density for Atg13 was clearly visible only
in the Vac8 contact region (residues 660–685), and all other
residues were disordered in the structure, consistent with the
structure of tNvj1 bound to tVac8 (Figure S1A) [24]. It is
noteworthy that, while the tVac8-tNvj1 complex forms
a heterotetramer comprising 2 tVac8-tNvj1 molecules that are
organized via contacts with ARM1 of Vac8 (Figure 1D, right),
such self-association of tVac8 was not observed in the structure
of the tVac8-tAtg13 complex. Instead, as we proposed in
a putative working model in our previous study [24], the H1
helix directly binds to ARM1 and eventually masks the dimeric
interface (Figure 1E, left). The residues comprising the H1 helix
in the tVac8-tAtg13 complex are different from those in the
tVac8-tNvj1 complex. In particular, this helix is extended by 6
residues that are disordered in the structure of the tVac8-tNvj1
complex (Figure 1E). The side chain of Glu24 and the main
chain carbonyl oxygen of Lys38 from the H1 helix engage in
direct H-bonds with Ser58 and Lys77 of ARM1, respectively. In
addition, the side chain of Lys38 of the H1 helix forms a salt
bridge with the side chain of Glu73 of ARM1. Furthermore,
Val28, Leu31, and Leu35 of H1 helix form a hydrophobic core
with Ala51, Leu52, and Leu55 of ARM1 that are known to be key
residues for self-association of Vac8 (Figure 1F).
Binding interface of tVac8 and tAtg13
Next, we further explored the interaction between tVac8 and
tAtg13. Based on the structural conservation between tAtg13
and tNvj1, we divided the tVac8-binding region of tAtg13
into 2 parts (interface I and II) (Figure 2A). The N-terminal
residues 660–671 (interface I) appear to interact loosely with
ARMs 7–10 of tVac8, whereas the C-terminal residues
672–685 (interface II) are specifically recognized and tightly
bound by ARMs 2–6 via both H-bonds and van der Waals
interactions, resulting in a buried surface area of 956.28 Å2,
which is nearly twice that of interface I (Figure 2B). In inter-
face II, the structure of tAtg13 strongly resembles that of
tNvj1 despite their negligible sequence homology (6%
sequence identity between Atg13 and Nvj1; Figure 2A,B). In
particular, Ile662 and Pro663 of tAtg13 in interface I form
hydrophobic contacts with the side chains of Ala398, Ala401,
Ile402, and Leu405 of tVac8, and His669 of tAtg13 forms
intermolecular H-bonds with Arg317 and Glu395 of tVac8
(Figure 2C). In interface II, Phe678 of tAtg13 engages in
extensive hydrophobic interactions with the side chains of
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Tyr226, Tyr227, and Leu192 of tVac8. Ala680, Phe684, and
His685 at the C terminus of tAtg13 also form a tight hydro-
phobic network with Leu192, Ala107, and Val103 of tVac8
(Figure 2C). In addition to these extensive hydrophobic
contacts, the side chains of Gln679 and Gln681 from tAtg13
form intermolecular H-bonds with the side chains of Lys160
and Asn152 from tVac8, respectively. The main chain atoms
of Gln679, Phe684, and His685 of tAtg13 are recognized by
Figure 1. Structure of the tVac8-tAtg13 complex. (A) Domain structures of Saccharomyces cerevisiae Atg13 and Vac8. Previously identified conserved domains are
marked by colored boxes, and the binding regions of associated proteins are indicated below. Residues 567–695 of Atg13 (designated as tAtg13) and residues
10–515 of Vac8 (designated as tVac8) were used for crystallization and biochemical experiments in this work. HORMA, Hop1, Rev7 and MAD2 domain; MIM,
microtubule interacting and transport (MIT)-interacting motif. (B) Analytical ultracentrifugation (AUC) analysis of the molecular weight (M.W.) of the tVac8-tAtg13
complex in solution. The bottom panel indicates a representative plot of absorbance profiles of 2.5 μM tVac8-tAtg13 following a centrifugation run at 13,604 × g for
16 h at 20°C, and the top panel presents the residuals between the experimental data and the fitted line. (C) Overall structure of tAtg13 (purple) bound to the
armadillo (ARM) repeat core of Vac8 (yellow). The structure was determined by molecular replacement using tVac8 as a search model (PDB code: 5XJG) and refined to
2.9 Å resolution (Table S2). The H1 regulatory helix of Vac8 is highlighted in orange (see the main text for an explanation of the role of the H1 helix). (D) Comparison
of the overall structures of tVac8-tAtg13 in (C) and tVac8-tNvj1, and the structure of the tVac8 (blue)-tNvj1 (orange) complex displayed in the same orientation as in
(C). A previous study revealed that the tVac8-tNvj1 complex forms a heterotetramer as shown on the right [24], while the tVac8-tAtg13 complex in (C) forms
a heterodimer. The arrangement of the H1 helix in the tVac8-tNvj1 complex is emphasized as a purple cylinder. (E) Cartoon representation comparing the
conformation of the H1 helices of tVac8-tAtg13 and tVac8-tNvj1 complexes. In the tVac8-tAtg13 structure (left), the H1 helix (orange) is composed of residues 21–40,
and is directly associated with 2 helices of the first ARM (ARM1). By contrast, the H1 helix in the tVac8-tNvj1 complex (right, purple) consists of residues 19–33, which
point away from ARM1 via a disordered loop comprising residues 35–40 (dotted line). (F) Cartoon representation showing the interactions between the H1 helix
(orange) and ARM1 (pale yellow) of tVac8 in the structure of the tVac8-tAtg13 complex. Residues involved in the interaction are shown in ball-and-stick
representation. Oxygen and nitrogen atoms are colored red and blue, respectively, and blue dotted lines indicate hydrogen bonds.
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Figure 2. Binding interface between tAtg13 and tVac8. (A) Ribbon representation showing the superposition of tNvj1 (blue green) and tAtg13 (purple), which are
bound to tVac8. Based on structural conservation, the structures of tAtg13 and tNvj1 can be divided into 2 subregions (designated as interface I and II). The bottom
box shows a close-up view of the C terminus, highlighting the structural comparison. (B) Sequence alignment of tNvj1 and tAtg13 based on their structures shown in
(A). Bar graphs indicate the percentage of buried surface area of each residue of tNvj1 (top) and tAtg13 (bottom), which were generated by the interaction with
tVac8. Each buried surface area of interface I and II of tAtg13 to tVac8 is shown in parentheses. Identical and similar sequences are highlighted in bold red and
normal red, respectively. (C) Ribbon representation showing protein-protein contacts identified in the crystal structure. Contacts between tVac8 (yellow) and tAtg13
(purple) are indicated by dotted lines (H-bonds) and red lines (hydrophobic interactions). Oxygen atoms are colored red, and nitrogen atoms are blue. (D) His6-tag
affinity-isolation analysis of the interaction of tVac8 and tAtg13. N-terminal glutathione-S-transferase (GST)-fused tVac8 was co-expressed with wild-type (WT) and
mutants of hexa histidine (His6)-tagged tAtg13, and immobilized on Ni
2+-NTA resin. Proteins were separated by 12% SDS-PAGE and visualized by Coomassie Brilliant
Blue staining. The N-triple mutant was generated by mutation of 3 residues in interface I (I662E P667E H669A). For the triple mutant, residues indicated by asterisks
were simultaneously mutated. Quantification data are shown on the right (n = 3). (E) Interface II is important for the Atg13-Vac8-mediated Cvt pathway of Ape1.
Vacuoles of yeast strains expressing wild-type or mutant Atg13 were labeled with FM 4–64 in YPD media at 30°C for 2 h. After free dye was removed, cells were
resuspended in a nitrogen starvation medium (SD-N) and further cultured at 30°C for 2 h. GFP fluorescence from Ape1 and FM 4–64 fluorescence in vacuoles were
then analyzed by fluorescence microscopy. Representative images from each cell type are shown (left). The graph shows quantification of cytoplasmic or vacuolar
Ape1-EGFP (right). More than 100 cells with Ape1-EGFP were analyzed per strain. Scale bar: 5 μm.
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the side chains of Asn193, Asn186, and Asn145 of tVac8
through intermolecular H-bonds (Figure 2C).
To characterize the interaction of Vac8 and Atg13 in solution,
we generated a series of tAtg13 mutants conjugated with a hexa
histidine (His6)-tag at the N terminus, and co-expressed each
mutant with glutathione-S-transferase (GST)-tagged tVac8. As
shown in Figure 2D, affinity-isolation experiments revealed that
mutations in interface I did not affect the interaction, whereas
single mutation of residues Phe678, Ala680, or Phe684 in inter-
face II reduced association with tVac8. Consistently, triple muta-
tion (F678R A680E F684E) of interface II completely abolished
association with tVac8. We also measured binding constants
(Kd) between Vac8 and tAtg13 mutants using isothermal titra-
tion calorimetry (ITC), and confirmed the results of affinity-
isolation experiments (Figure S2). To investigate the importance
of interface II in vivo, we examined the Cvt pathway of Ape1,
which requires the Vac8-Atg13 interaction [23], by expressing
one of the Atg13 mutants harboring a mutation in interface II in
atg13Δ yeast cells (Figure 2E). While green fluorescent protein
(GFP)-conjugated Ape1 was transported to the vacuolar lumen
via the Cvt pathway in nearly 90% of wild-type yeast cells upon
nitrogen starvation, only 10% of atg13Δ cells contained GFP-
Ape1 in the vacuolar lumen. Cytoplasmic GFP puncta, indicative
of defects in the Cvt pathway, were observed in most atg13Δ
cells, confirming that Atg13 is essential for the Cvt pathway of
Ape1 (Figure 2E). Furthermore, although each of the single
mutations in interface II resulted in a minor defect in the Cvt
pathway of Ape1, the defect was multiplied in cells expressing
the Atg13 mutant with all 3 mutations (F678R A680E F684E),
demonstrating that interface II is critical for the interaction
between Atg13 and Vac8, and thereby their function in the Cvt
pathway (Figure 2E). Consistently, vacuolar processing of
prApe1, which requires the Cvt pathway, was impaired by
these mutations in interface II (Figure S3A–C). By contrast, the
mutant bearing all 3 mutations (I662E P667EH669A; referred to
as N-triple) in interface I supported the Cvt pathway comparably
to wild-type, consistent with the results of the in vitro affinity-
isolation assay of the N-triple mutant (Figure 2D; Figure S3D).
In addition, a recent study elucidated 2 sets of motifs com-
prising positively charged residues (640KFK642 and 683KFHK686)
in the Atg13 intrinsic disordered region (IDR, residues
571–700), which are responsible for interactions with phospho-
lipids that are essential for efficient autophagy (Gatica et al., co-
submitted manuscript). Among these positively charged
residues, Lys683 and His685 are observable in the tVac8-
tAtg13 structure, and their side chains are exposed to bulk
solvent at the surface of the molecule (Figure 2C), further
supporting their interactions with phospholipids. The presence
of this second motif (683KFHK686) in interface II is also con-
sistent with our observation that interface II is critical for the
Cvt pathway (Figure 2E).
Structure of Vac8[Δ19–33] in complex with tAtg13
Based on combined structural and biochemical results, we
proposed that a flexibly linked H1 helix is involved in regulat-
ing self-association of Vac8 through a folding-back mechanism
in which the H1 helix binds ARM1 and masks the dimeric
interface [24]. To advance our understanding of how the H1
helix regulates the self-association of Vac8, we generated an
internal deletion construct lacking the H1 helix (residues
19–33; hereafter referred to as Vac8[Δ19–33]; Figure 3A). We
measured the binding affinity using ITC and found that Vac8
[Δ19–33] bound to tAtg13 with a Kd of 1.46 μM, indicating
that deletion of the H1 helix only had a slight influence on the
binding affinity (Figure 3B). Notably, AUC analysis confirmed
that Vac8[Δ19–33]-tAtg13 indeed formed a heterotetramer in
solution (Figure 3C). The Vac8[Δ19–33]-tAtg13 complex was
crystallized in space group P212121 with 2 copies of the com-
plex in the asymmetric unit, and the structure was solved by
molecular replacement, and eventually refined at 3.2 Å resolu-
tion with Rwork/Rfree values of 0.22/0.25 (Figure S1B; Table S2
for data collection and refinement statistics).
A molecular model of Vac8[Δ19–33] bound to tAtg13 is
presented in Figure 3D. As demonstrated by AUC experiment
(Figure 3C), the Vac8[Δ19–33]-tAtg13 complex forms
a heterotetramer, with 2 complexes self-associated through
ARM1 of Vac8, adopting a superhelical shape with overall
dimensions of 51 × 57 × 213 Å, that turns twice along the
superhelical axis. Unlike tVac8-tAtg13 or tVac8-tNvj1 com-
plexes that include a truncated Vac8 terminating at
C-terminal residue 515, full-length Vac8 was used in the
Vac8[Δ19–33]-tAtg13 complex, although the H1 helix was
deleted. In the Vac8[Δ19–33]-tAtg13 structure,
Vac8 N-terminal residues 1–18 remain disordered, indicating
that this region is intrinsically flexible, even though corre-
sponding sequences are highly conserved in other species.
More importantly, the structure revealed that the C-terminal
end is absolutely required to form an intact final armadillo
repeat (ARM12). In our previous tVac8-tNvj1 study, we
showed that C-terminal truncation of Vac8 results in an
incomplete α2 helix of Vac8 ARM12 [24]. According to the
structure revealed in the present study, the α2 helix is
extended up to residue 527, and the α3 helix starts at residue
560 and finishes at residue 578, which is the C-terminal end
(Figure 3E). The 27 residues from 533 to 559 that connect α2
and α3 helices of ARM12 are disordered in the structure.
Based on this observation, we conclude that full-length
sequences are absolutely required to form all 12 ARMs in
Vac8. Given that proper organization of all ARMs might be
critical for structural integrity, the whole sequence of Vac8 is
likely important for performing biological functions. Indeed,
the binding affinity of tVac8 for tNvj1 is reduced by 7-fold
compared with the full-length Vac8 despite the fact that
ARM12 does not directly contribute to the interaction [24].
The structure of tAtg13 bound to Vac8[Δ19–33] at inter-
face I revealed a different conformation compared with the
tVac8-tAtg13 complex (Figure 3F; Figure S4). In particular,
the N-terminal 5 residues of tAtg13 are disordered in the
structure of tAtg13 bound to Vac8[Δ19–33], and the interac-
tions of Vac8[Δ19–33] and Atg13 in interface I differ from
those in the tVac8-tAtg13 complex (Figure 2C, 3F; Figure
S4A,B). Consistent with the tVac8-tAtg13 complex, contacts
contributed by interface I do not appear to be strong, and
only 525 Å2 of solvent-accessible surface area is buried.
Detailed analysis in Figure S4C,D indicated that the confor-
mation of tAtg13 bound to Vac8[Δ19–33] is more likely in
solution because the N-terminal structure of tAtg13 bound to
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tVac8 appears to be affected by neighboring molecules due to
crystal packing. The structure of tAtg13 at interface II in the 2
crystal structures superimposed precisely, suggesting that
these interactions are orderly and functionally important
(Figure S4B).
Dimerization of Vac8 in the Vac8-Atg13 complex
Self-association of Vac8 is required for formation of the
nucleus-vacuole junction (NVJ) [24]. Herein, we also showed
that Vac8 bound to Atg13 oligomerized through ARM1 of
Figure 3. Structure of Vac8[Δ19–33] in complex with tAtg13. (A) Schematic diagram showing the organization of the ARMs of Vac8 revealed in this study. To investigate the role
of the H1 helix in the self-association of Vac8, a truncated construct lacking the H1 helix (Vac8[Δ19–33]) was generated. (B) Isothermal titration calorimetry (ITC) analysis of
tAtg13 binding to Vac8. The tAtg13 protein was titrated into full-length Vac8 (left) or Vac8[Δ19–33] (right) at 25°C. The upper panel shows raw data, and the lower panel shows
data fitted to binding isotherms to calculate affinities. The table below thermograms summarizes the measured thermodynamic parameters. (C) AUC analysis of the molecular
weight (M.W.) of the Vac8[Δ19–33]-tAtg13 complex performed as described in Figure 1B. (D) Overall structure of the Vac8[Δ19–33]-tAtg13 complex. Two copies of Vac8[Δ19–33]
(cyan and pink) bound to tAtg13 (orange and green) are associated in the crystal asymmetric unit. Unlike tVac8-tAtg13 (Figure 1C), Vac8[Δ19–33]-tAtg13 forms a heterotetramer
organized by self-association of ARM1 of Vac8[Δ19–33]. In the structure, Vac8[Δ19–33] has 12 intact ARMs, and tAtg13 binds to the inner groove generated by the ARMs of Vac8
[Δ19–33] in an antiparallel manner. (E) Schematic diagram (left) illustrating the 3 types of ARMs present in the structure of Vac8[Δ19–33]. ARMs 1–2 consist of only 2 helices (α2
and α3; labeled to show the organization of helices in ARMs) that play important roles in Vac8 self-association. ARMs 3–11 have a typical ARM repeat comprising 2 short helices
(α1 and α2) and a long helix (α3). ARM12 consists of a short helix (α1) and a relatively long helix (α2) followed by a long disordered region (residues 533–559) and helix α3. The
right panel shows the structure of ARM12 in the Vac8[Δ19–33]-tAtg13 complex. (F) Close-up view of Atg13 (green) bound to Vac8[Δ19–33] (yellow) oriented as in Figure 2C.
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Vac8 (Figure 3D). Figure 4A highlights the 2-fold interface
generated by pairwise arrangement of helices α2 and α3 from
ARM1 of each subunit. Ser66 lies at the center of the 2-fold
symmetry axis, and Glu73 engages in an H-bond with Asn62
of the other subunit. In addition, Ala51 and Leu52 form van
der Waals contacts with Leu55, Leu63, and Ala70 of the other
subunit (Figure 4A). To confirm that ARM1 is important for
Vac8 dimerization in solution, we performed site-directed
mutagenesis to generate the A51R and L55R mutants with
altered contact sites, and conducted size-exclusion chromato-
graphy (SEC) with Vac8[40–515] lacking residues 1–39, also
used in our previous study [24]. The Vac8[40–515]-tAtg13
complex migrated with a retention time consistent with the
heterotetramer, while mutants eluted from the column as
apparent heterodimers (Figure 4B).
To further assess if Vac8 self-association is critical for the
Cvt pathway, we replaced wild-type Vac8 with a mutant har-
boring A51R or L55R mutation, and examined whether the
mutants support the Cvt pathway of Ape1 (Figure 4C). The
results revealed that the Cvt pathway of Ape1 was impaired in
yeast cells expressing the Vac8 mutants defective for self-
association, clearly indicating that Vac8 dimerization in the
Vac8-Atg13 complex is critical for the Cvt pathway.
Consistently, conversion of the precursor form of Ape1
(prApe1) to the mature form of Ape1 in the vacuole was
markedly impaired by A51R or L55R mutation (Figure S5).
Triton X-114 phase partitioning confirmed that the Vac8
mutants did not affect myristoylation or palmitoylation, and
thus the vacuolar targeting of Vac8 (Figure S6).
Structural comparison of Vac8-Atg13 and Vac8-Nvj1
complexes
As highlighted in Figure 5A, self-associated Vac8 exhibits striking
differences in quaternary organization when binding to Atg13 or
Nvj1. When bound to Nvj1, 2 Vac8 molecules are arranged via
2-fold symmetry around the axes of the ARM1 helices, resulting in
an arch-shaped structure (Figure 5A,B, left). By contrast, when
bound to Atg13, 2 Vac8 molecules adopt a superhelical structure
Figure 4. ARM1 of Vac8mediates self-association of Vac8 in the Vac8-Atg13 complex. (A) Close-up view of the 2-fold dimeric interface of Vac8[Δ19–33]. Residues involved in
the self-association of ARM1 are displayed in ball-and-stick representation. Intermolecular hydrogen bonds are indicated with blue dotted lines, and oxygen and nitrogen
atoms are colored red and blue, respectively. (B) Size-exclusion chromatography (SEC) of wild-type and mutant (A51R or L55R) of Vac8[40–515] in complex with tAtg13. The
indicated protein mixtures were applied to a Superdex 200 10/300 GL column equilibrated with buffer containing 25 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5 mM DTT. The
molecular weights of standard proteins are presented above the curves to compare the relative molecular mass (blue dextran 2000, void; ferritin, 440 kDa; aldolase, 158 kDa;
conalbumin, 75 kDa; ovalbumin, 44 kDa). (C) Vac8 self-association in the Vac8-Atg13 complex is critical for the Cvt pathway of Ape1. Vacuoles of yeast strains expressing
wild-type or mutant Vac8 were labeled with FM 4–64 in YPD media at 30°C for 2 h. Experiment was performed as described in Figure 2E. Representative images (left) are
shown for each strain. The graph shows quantification of cytoplasmic or vacuolar Ape1-EGFP (right). Scale bar: 5 μm.
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in which the first ARMs are organized via 2-fold rotation symme-
try around the axis perpendicular to the plane (Figure 5A,B, right).
To confirm the distinct organization of Vac8 dimers in solu-
tion, we performed synchrotron small-angle X-ray scattering
(SAXS) experiments using Vac8[40–578]-tNvj1 and Vac8
[40–578]-tAtg13 complexes (Figure 5C,D; Table S3), in which
Vac8 construct comprising residues 40–578 was used for mini-
malizing flexible regions and obtaining information from the
complete ARM domain. The radius of gyration (Rg) calculated
from one-dimensional experimental scattering plot of the Vac8
[40–578]-tNvj1 complex (57.82 Å) was different from that of
Vac8[40–578]-tAtg13 (60.40 Å; Figure 5C,D, left). However,
Figure 5. Binding of Atg13 or Nvj1 affects the quaternary structure of Vac8. (A) Surface representation of the tVac8-tNvj1 (left) and Vac8[Δ19–33]-Atg13 (right)
heterotetrameric structures. In the crystal structures, 2 complexes of tVac8-tNvj1 adopt an arched shape. By contrast, 2 copies of Vac8[Δ19–33]-tAtg13 are arranged
via 2-fold symmetry along the axis perpendicular to the plane, resulting in a superhelical shape. (B) The organization of ARM1 at the 2-fold interface in tVac8-tNvj1
(left) and Vac8[Δ19–33]-tAtg13 (right) heterotetramers. Arrows indicate the direction of the helical axis. (C and D) Small-angle X-ray scattering (SAXS) experimental
data showing different quaternary structures of Vac8-Nvj1 (C) and Vac8-Atg13 (D). Experimental scattering data (hollow circles) of Vac8[40–578]-tNvj1 (C, left) or Vac8
[40–578]-tAtg13 (D, left) agree well with theoretical scattering curves (blue line) calculated from structures of Vac8[Δ19–33]-tNvj1 or Vac8[Δ19–33]-tAtg13. A Guinier
plot of Vac8[40–578]-tNvj1 (C) and Vac8[40–578]-tAtg13 (D) is shown on the left. The middle panels show the distance distributions and maximum dimensions (Dmax)
of Vac8[40–578]-tNvj1 (C) and Vac8[40–578]-tAtg13 (D). Envelopes calculated from Vac8[40–578]-tNvj1 (C, right) and Vac8[40–578]-tAtg13 (D, right) SAXS data align
well with structures of Vac8[Δ19–33]-tNvj1 and Vac8[Δ19–33]-tAtg13, respectively. The alignment was carried out using SUPCOMB [46], and model and envelope
representations were generated by Chimera [48].
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experimental SAXS scattering data of Vac8[40–578]-tNvj1 or
Vac8[40–578]-tAtg13 complexes fitted well to theoretical scat-
tering curves calculated from the structure of Vac8[Δ19–33]-
tNvj1, in which tVac8 coordinates of the tVac8-tNvj1 were
replaced by that of Vac8[Δ19–33], or Vac8[Δ19–33]-tAtg13
crystal structures, respectively, in good agreement with theore-
tical Rg values (58.35 Å for Vac8[Δ19–33]-tNvj1 and 62.01 Å for
Vac8[Δ19–33]-tAtg13; Figure 5C,D, left). The maximum
dimension (Dmax) value for Vac8[40–578]-tNvj1 (217.6 Å) cal-
culated from the P(r) distance distribution function was different
from that of Vac8[40–578]-tAtg13 (229.3 Å; Figure 5C,D, mid-
dle). Most strikingly, the envelopes derived from Vac8[40–578]-
tNvj1 and Vac8[40–578]-tAtg13 revealed distinctive quaternary
structures in solution (Figure 5C,D, right). In particular, the
SAXS envelope obtained from Vac8[40–578]-tNvj1 displayed
an arched shape that superimposed well with the structure of
the Vac8[Δ19–33]-tNvj1 heterotetramer (Figure 5C, right),
whereas the envelope obtained from Vac8[40–578]-tAtg13
clearly adopted an extended rod shape that aligned well with
the superhelical structure of the Vac8[Δ19–33]-tAtg13 complex
(Figure 5D, right). In addition, the molecular weights of the
Vac8[40–578]-tNvj1 and Vac8[40–578]-tAtg13 complexes mea-
sured by SAXS using Qp [28] were 132.16 kDa and 139.13 kDa,
respectively, and these were also consistent with the heterote-
tramer complexes (2 × Vac8[40–578]-tNvj1 and 2 × Vac8
[40–578]-tAtg13; Table S3). Taken together, the SAXS data
strongly support the crystal structures, revealing that Vac8
adopts different quaternary structures in solution depending
on its binding partners.
Quaternary structures of Vac8 differentially affect Cvt
and PMN pathways
To confirm whether the characteristic organization of Vac8 is
altered by binding of Atg13 or Nvj1 in solution, Vac8[40–515]
mutations were generated. Ala51, involved in the association
in both the arched and superhelical Vac8 structures, was
mutated first, followed by Asn60 and Asn62 that contribute
to the superhelical organization of Vac8 but project outward
in the arched structure, and thus are not involved in the
interaction (Figure 5B). Chemical cross-linking experiments
followed by immunoblotting analysis with Nvj1 or Atg13
antibodies revealed that the A51R mutant failed to undergo
self-association in the presence of tNvj1 or tAtg13, consistent
with the SEC experiments (Figure 4B, 6A,B) [24].
Interestingly, the N62R single mutation or N60R N62R dou-
ble mutation did not affect self-association of Vac8[40–515]
bound to tNvj1, whereas the self-association of Vac8[40–515]
was significantly reduced in the Vac8[40–515]N60R,N62R-
tAtg13 complex (Figure 6A,B; Figure S7). Consistent with
these results, the N62R single mutant of Vac8[40–515] com-
plexed with tAtg13 eluted later from the SEC column, and the
N60R N62R double mutation resulted in a more severe defect
than the N62R single mutation while these mutants bound to
tNvj1 eluted at heterotetrameric size (Figure 6C,D). Taken
together, the results showed that mutation of residues Asn60
and Asn62 only affected the superhelical conformation gen-
erated by formation of the Vac8-Atg13 complexes,
corroborating the idea that the quaternary organization of
Vac8-Atg13 is clearly different from that of the Vac8-Nvj1
complex.
To investigate the biological relevance of Atg13-specific Vac8
organization, we examined whether the Vac8N60R,N62R mutant
supported the Cvt or PMN pathways (Figure 6E,F). As shown in
Figure 6F, the Vac8N60R,N62R mutant failed to support the Cvt
pathway, but interestingly, the PMN pathway was not affected
(Figure 6E). These results strongly suggest that Vac8 adopts
different quaternary structures depending on its binding part-
ners, and in doing so mediates different cellular processes.
Discussion
Vac8 is composed of 12 ARMs across the whole sequence, and
has a myristoylation and 3 palmitoylation sites in the
N-terminal region for anchoring into vacuolar membranes,
followed by an H1 helix, and ARM1 starts at residue 41
(Figure 1E) [14,15,17,24]. In a previous study, we suggested
that the H1 helix plays a pivotal role in regulating the
dynamic organization of Vac8 [24]. The present study con-
firmed this putative regulation mechanism by showing that
the H1 helix directly interacts with ARM1 and hinders the
dimeric interface (Figure 1C,E). In more detail, the
N-terminal H1 helix is placed next to ARM1 that also serves
as a binding interface for the formation of the 2-fold dimer of
Vac8 (Figure 1E). Intramolecular association of the H1 helix
and ARM1 regions blocks exposure of the 2-fold interface,
thereby hindering self-association of Vac8, which is crucial for
the PMN and Cvt pathways. We previously reported that
disruption of Vac8 dimerization markedly affects both PMN
and Cvt pathways [24] (also see Figure 4C). Structural com-
parison of tVac8-tNvj1, in which the H1 helix is dissociated
from ARM1 (referred to as “active”; Figure 1D), and tVac8-
tAtg13 in which the H1 helix is bound to ARM1 (referred to
as “inactive”; Figure 1C), revealed that the residues compris-
ing the H1 helix are altered between active and inactive
conformations. In the “inactive” conformation, the
C terminus is extended by 6 residues that are disordered in
the “active” conformation (Figure 1E). The dynamic organi-
zation of the sequence and structure of the H1 helix could in
principle regulate the conversion from the “inactive” to the
“active” states. The regulatory importance of the H1 helix is
further supported by high sequence conservation across Vac8
homologs; even the residues in the disordered region (resi-
dues 35–40) of the “active” state are highly conserved among
other species [24].
Given that the self-association of Vac8 is important for
both PMN and Cvt pathways, it is noteworthy that one role
of the H1 helix might be to initiate these pathways. We
therefore attempted to identify factors triggering conforma-
tional changes in the H1 helix by focusing on a possible
covalent modification in the vicinity of this secondary struc-
tural element. Interestingly, global analysis of phosphorylation
sites in the cyclin-dependent kinase Cdk1 in S. cerevisiae
identifies residues Ser11 and Ser16 of Vac8 as strong candi-
date sites for Cdk1-mediated phosphorylation [29]. Ser11 is
disordered in the structure of both tVac8-tAtg13 and Vac8
[Δ19–33]-tAtg13 complexes, suggesting that this region is
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Figure 6. Different quaternary structures affect Cvt and PMN pathways. (A and B) Glutaraldehyde-mediated cross-linking of WT and mutant Vac8[40–515] complexed
with tNvj1 (A) or tAtg13 (B). Proteins (0.5 mg/mL) were mixed with 0.001% glutaraldehyde (G.A) and incubated at 20°C for 30 min. Reaction products were separated
by 8% SDS-PAGE, transferred to a PVDF membrane, and immunoblotted with anti-Nvj1 or anti-Atg13 antibody. T and D indicate Vac8[40–515]-tNvj1 (A) or Vac8
[40–515]-tAtg13 (B) heterotetramer and heterodimer complexes, respectively. (C and D) SEC analysis of the N62R single mutant and N60R N62R double mutant of
Vac8[40–515] complexed with tNvj1 (C) or tAtg13 (D). The experiment was performed as described in Figure 4B. T and D indicate the elution volumes of Vac8
[40–515]-tNvj1 (C) or Vac8[40–515]-tAtg13 (D) heterotetramer and heterodimer complexes obtained from our previous study [24] and Figure 4B, respectively. (E)
Piecemeal microautophagy of the nucleus (PMN) is largely intact in cells expressing the N60R N62R Vac8 double-mutant. Cells expressing Nvj1-EGFP were treated
with 0.2 μM rapamycin for 6 h to induce PMN. GFP fluorescence from Nvj1 and red fluorescence (FM 4–64) from vacuoles were analyzed by fluorescence microscopy.
Representative images (left) from each cell type with or without rapamycin (scale bar: 5 μm) and quantification (right) of cells with PMN bleb or PMN vesicles are
shown. Yeast strains lacking the major vacuolar protease Pep4 were used to block the degradation of PMN blebs or vesicles in the vacuolar lumen. (F) The Vac8N60R,
N62R mutant does not support the Cvt pathway. Vacuoles of wild-type yeast cells, vac8Δ cells, and vac8 (N60R,N62R) cells were labeled with FM 4–64 in YPD media at
30°C for 2 h. Experiment was performed as described in Figure 2E. Representative images (left) are shown for each strain. The graph shows quantification of
cytoplasmic or vacuolar Ape1-EGFP (right). Scale bar: 5 μm.
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structurally flexible. Meanwhile, Ser16 is visible in the tVac8-
tAtg13 complex, and the side chain is exposed to the surface
and hence solvent-accessible (Figure S8). Moreover, because
its side-chain hydroxyl group does not participate in any
intermolecular interactions with other residues, this residue
could potentially be phosphorylated by kinases. More impor-
tantly, Ser16 is located just beneath the N terminus of the H1
helix, indicating that modification of this residue could affect
the conformation of the H1 helix (Figure S8).
To explore whether Ser11 and/or Ser16 are phosphorylated
in vivo, we attempted to identify phosphorylation sites of Vac8
by LC-MS/MS analysis (Figure 7A). The results revealed that
Ser16 was indeed phosphorylated, but we failed to detect phos-
phorylation of Ser11. Although these results do not necessarily
rule out the possibility that Ser11 is a phosphorylation site, we
focused on investigating the importance of Ser16 in the regula-
tion of Cvt and PMN pathways by mutating this residue to
alanine or glutamate. As shown in Figure 7C,D, both PMN
and Cvt pathways were severely impaired when Ser16 was
replaced with alanine. Intriguingly, these pathways were simi-
larly impaired when Ser16 was replaced with glutamate,
a phosphomimetic amino acid (Figure 7E,F). Given that the
alanine or glutamate mutation did not impair the vacuolar
localization of Vac8 (Figure 7B), these results strongly suggest
that Ser16 is essential for the PMN and Cvt pathways, and its
phosphorylation must be elaborately controlled in
a spatiotemporal manner for these pathways [30]. Our results
imply that the fundamental functions of Vac8may potentially be
regulated by signal-mediated processes through phosphoryla-
tion, although it remains elusive whether phosphorylation of
Ser16 per se might directly cause structural changes in the H1
helix, resulting in switching between its active and inactive
conformations (Figure 7G). In the same vein, our findings also
imply that the formation of membrane contact sites, such as
NVJs, may be regulated by external signaling pathways.
Activation or inhibition of these pathwaysmay trigger formation
or disruption of NVJs, and thereby regulate PMN bymodulating
the structures and functions of Vac8.
An intramolecular folding-back mechanism acting on
ARM-containing proteins has been suggested for the
CTNNB1/β-catenin-CDH1/E-cadherin complex that plays
essential roles in cell-cell adhesion [31]. The structure of
CDH1/E-cadherin bound to CTNNB1/β-catenin, which pos-
sesses 12 ARMs [32], strongly resembles those of the Vac8-
Atg13 and Vac8-Nvj1 complexes determined in the present
study (Figure 1C) [24]. The additional secondary structural
elements at the N- and C-termini of CTNNB1/β-catenin, rather
than within the central ARM domain, are involved in interac-
tions with other binding partners or self-association with the
ARM domain itself, and thereby differentially regulate molecu-
lar functions in cell adhesion and WNT signaling [31,33].
Although it has never been reported that the H1 helix of
Vac8 mediates interactions with other proteins, we herein
propose a similar versatile role for the H1 helix in regulating
the function of Vac8 by modulating inter- and/or intramole-
cular binding in a comparable manner. Interestingly, however,
expression of Vac8 mutant lacking the H1 helix, Vac8[Δ19–33],
in vac8Δ yeast cells fully restored the PMN pathway, but not
the Cvt pathway, suggesting that the H1 helix plays a complex
functional role, possibly acting as a switch elaborately regulated
by phosphorylation (Figure S9).
Vac8 also plays an important role in forming NVJs, and
therefore represents novel membrane contact sites. NVJs are
formed by direct interaction between Vac8 and Nvj1, and we
demonstrated that disruption of this interaction prevents the
formation of NVJs, and consequently blocks the PMN path-
way [24]. Structural comparison of tVac8-tAtg13 and tVac8-
tNvj1 complexes revealed several common features; both
tNvj1 and tAtg13 form extended loops in the Vac8-binding
region that competitively bind in an antiparallel manner to
the inner groove generated by the Vac8 ARM domain (Figure
1C,D) [24]. While obvious structural variations between the 2
extended loops were apparent at interface I of the N-terminal
region, interface II in the C-terminal region of the 2 structures
superimposed well, despite the low sequence identity shared
between Nvj1 and Atg13 (Figure 2A,B). Interestingly, the
contact region at interface II is very close to ARM1 that is
critical for self-association of Vac8. The most remarkable
structural variation between Vac8[Δ19–33]-tAtg13 and tVac8-
tNvj1 was the clear difference in conformation of the qua-
ternary structures of Vac8 bound to Nvj1 or Atg13. When
bound to Nvj1, the Vac8 heterotetramer forms an arch-
shaped structure, whereas it adopts a superhelical conforma-
tion in the Vac8-Atg13 complex (Figure 5). We experimen-
tally confirmed that the organization of the quaternary
structures of Vac8 selectively affected Cvt or PMN pathways
in yeast (Figure 6E,F). We therefore investigated how the
quaternary conformation of Vac8 is altered, and structure
alignment of Nvj1 and Atg13 revealed an additional visible
residue (Tyr321) in tNvj1, in interface II at the C terminus,
that is clearly involved in dimerization of Vac8 (Figure 2A,B;
Figure S10). Consistently, we previously proposed
a significant role for Tyr321 in self-association of Vac8 and
formation of NVJs [24]. The absence of this residue in Atg13
could prevent Vac8 from adopting an arch-shaped structure,
favoring a different Vac8 conformation. It is still unknown
whether there are other proteins that specifically recognize the
different quaternary structures of Vac8, and future work
should address how the quaternary structures may contribute
to the cellular functions of Vac8 at the molecular level.
Nevertheless, our work provides a seminal framework for
understanding the molecular mechanism by which the arma-
dillo repeat protein Vac8 can differentially regulate the 2
distinct Cvt and PMN pathways at the molecular level.
Materials and methods
Cloning, expression, and protein purification
Overexpression constructs for glutathione-S-transferase (GST)-
fused tVac8 and His6-tagged tAtg13 proteins have been
described previously [34]. For the Vac8[Δ19–33]-tAtg13 com-
plex, DNA encoding Vac8[Δ19–33] was generated by PCR and
cloned into the vector pGEX-6P-1 (GE Healthcare Life
Sciences). For co-expression and purification of tVac8-tAtg13
and Vac8[Δ19–33]-tAtg13, plasmids were transformed into
Escherichia coli BL21 (DE3) competent cells, and cells were
grown in Luria-Bertani medium (MP Biomedicals, 113002032)
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to an absorbance at 600 nm (A600) of 0.6. Protein expression was
then induced by the addition of 0.3 mM isopropyl-β-
D-1-thiogalactopyranoside (IPTG; GoldBio, I2481), and cultur-
ing was continued at 18°C overnight. Cultured cells were har-
vested by centrifugation at 3,200 × g for 18min and resuspended
in buffer A containing 25 mM sodium phosphate, pH 7.8,
400 mM sodium chloride (NaCl), 10 mM imidazole. Proteins
were first purified on a HiTrap chelating HP column (GE
Healthcare Life Sciences, 17040901) charged with Ni2+ in buffer
A. The GST-tag and His6-tag were removed using PreScission
Figure 7. Phosphorylation of Ser16 in Vac8 may regulate the PMN and Cvt pathways. (A) Mass spectrometric analysis of phosphorylated peptides from trypsin
digestion of Vac8 reveals phosphorylation of residue Ser16 of Vac8. (B) Replacement of Ser16 with alanine or glutamate does not influence the vacuolar localization
of Vac8. GFP fluorescence from Vac8 and FM 4–64 fluorescence from vacuoles were analyzed by fluorescence microscopy. (C and D) Vac8S16A mutant does not
support the PMN (C) or Cvt (D) pathways. (E and F) Replacement of Ser16 with glutamate, a phosphomimetic amino acid, largely abolishes the function of Vac8 in
both the PMN (E) and Cvt (F) pathways. (G) Putative model of H1 helix-mediated regulation of Vac8. Vac8 is anchored in the vacuolar membrane via lipidation at the
N terminus. The H1 helix (purple) directly binds to ARM1 and hinders the self-association of Vac8 by masking the dimeric interface (left; “inactive” conformation). The
H1 helix can be released from ARM1, resulting in exposure of the dimeric interface, allowing its self-association (right; “active” conformation). The cartoon
representation proposes a putative model in which conformational changes of the H1 helix might be induced by phosphorylation (red circle) of Ser16 or unknown
factors (question mark).
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(GE Healthcare Life Sciences, 27084301) and tobacco etch virus
(New England BioLabs, P8112S) proteases, respectively, during
dialysis overnight against buffer containing 25 mM Tris-HCl,
pH 7.8, 150 mMNaCl, 4 mM β-mercaptoethanol (β-ME) at 4°C.
Non-cleaved proteins and cleaved tags were removed by
a second round of Ni2+-immobilized metal affinity chromato-
graphy (IMAC) and GST affinity chromatography. Proteins
were further purified by size-exclusion chromatography (SEC)
using a HiLoad 16/600 Superdex 200 pg column (GE Healthcare
Life Sciences, 28989335) in buffer B consisting of 25 mM Tris-
HCl, pH 7.5, 150 mM NaCl, 5 mM dithiothreitol (DTT).
Proteins were concentrated to 10 mg/mL for later use. Mutant
variants of Vac8 and tAtg13 used in this study were obtained by
site-directed mutagenesis and confirmed by DNA sequencing.
Crystallization and structure determination
The tVac8-tAtg13 complex was crystallized as described pre-
viously [34] from a reservoir solution comprising 25% (v:v)
polyethylene glycol (PEG) 400 (Sigma-Aldrich, 91893),
100 mM Tris-HCl, pH 8.5, 2% (v:v) ethylene glycol (Sigma-
Aldrich, 324558), 2% (w:v) PEG 3350 (Sigma-Aldrich, 88276),
5 mM DTT. Crystals were transferred into reservoir buffer
supplemented with 30% (v:v) PEG 400 for cryoprotection, and
flash-frozen in liquid nitrogen. X-ray diffraction data were
collected at a wavelength of 0.979 Å on beamline 5C of the
Pohang Accelerator Laboratory [35]. Data were processed
with the program HKL2000 [36]. The structure was solved
by molecular replacement using Phaser in the Phenix suite
[37] with published coordinates of Vac8 (PDB code: 5XJG) as
a search model. Following rigid-body and positional refine-
ment of the model using Phenix [38] and Coot [39], the
sequence of tAtg13 (residues 660–685) could be positioned
into the resulting electron density (Figure S1A). Subsequently,
restrained refinement reduced the free R-factor to 24.6% (and
the crystallographic R-factor to 20.6%) for data between 50
and 2.9 Å resolution (Table S2). Residues 10–12 and 514–515
of tVac8, and residues 567–659 and 686–695 of tAtg13, were
not modeled due to disordered electron density.
The Vac8[Δ19–33]-tAtg13 complex was crystallized at 4°C
by mixing 1 μL of protein solution with the same volume of
reservoir solution comprising 15% (w:v) PEG 3350, 0.1 M
N-(2-acetamido)iminodiacetic acid (ADA), pH 6.5, 0.2 M
ammonium sulfate. Crystals (space group P212121,
a = 69.475 Å, b = 85.268 Å, c = 272.820 Å) contain 2 copies
of the Vac8[Δ19–33]-tAtg13 complex in the asymmetric unit,
and diffract synchrotron X-rays to 3.2 Å resolution. Crystals
were transferred to well solution plus 30% (v:v) ethylene
glycol for cryoprotection and flash-frozen in liquid nitrogen.
X-ray diffraction data collection and phase calculation were
performed as described above. The final model of the Vac8
[Δ19–33]-tAtg13 complex was refined to Rwork/Rfree values of
21.6/25.5% following iterative rounds of refinement and
model building. The model contains residues 47–528 and
561–576 of Vac8[Δ19–33] for first copy, residues 48–532
and 560–578 of Vac8[Δ19–33] for second copy, and residues
665–685 of tAtg13 (Figure S1B). Diffraction data and refine-
ment statistics are summarized in Table S2. All structural
images in figures were generated by PyMOL (http://www.
pymol.org/).
Analytical ultracentrifugation
The absolute molecular weights of tVac8-tAtg13 (Figure 1B) and
Vac8[Δ19–33]-tAtg13 (Figure 3C) complexes were measured by
sedimentation equilibrium analysis using an XL-A analytical
ultracentrifuge (Beckman Coulter) as described previously
[40]. Protein samples were prepared in buffer C comprising
25 mM Tris-HCl, pH 7.5, 150 mM NaCl, 5 mM β-ME.
Affinity-isolation assay
To assess the interaction between Vac8 and Atg13 (Figure 2D),
supernatants of E. coli cells co-expressing GST-tVac8 and wild-
type or mutant His6-tAtg13 were incubated with 15 μL of Ni-
NTA agarose (Qiagen, 30210) for 1 h at 4°C. Beads were
washed 3 times with buffer consisting of 25 mM sodium phos-
phate, pH 7.4, 400 mM NaCl, 50 mM imidazole, 0.1% (v:v)
Triton X-100 (Sigma-Aldrich, X100). Proteins were eluted with
4× sodium dodecyl sulfate (SDS) loading buffer, separated by
12% SDS-polyacrylamide gel electrophoresis (PAGE), and
stained with Coomassie Brilliant Blue. Protein bands of Vac8
were quantified using ImageJ software. Data are shown as the
mean ± SD of 3 independent experiments.
Isothermal titration calorimetry
The apparent dissociation constant (Kd) for Vac8 (full-length
and Vac8[Δ19–33]) binding to tAtg13 proteins (Figure 3B)
and full-length Vac8 binding to mutants of tAtg13 (Figure S2)
was measured by isothermal titration calorimetry (ITC) using
a MicroCal iTC200 instrument (GE Healthcare Life Sciences).
A 0.7 mM sample of tAtg13 was titrated into 0.05 mM Vac8
protein in buffer C at 25°C. Measurements were obtained over
20 injections of 2 μL with a reference power of 5 μcal/s and
a stirring speed of 1000 rpm. The “one set of sites” model was
used to generate titration curves using MicroCal PEAQ-ITC
analysis software (Malvern panalytical).
Size-exclusion chromatography assay
To analyze the relative molecular weight of wild-type and
mutant Vac8-Atg13 complexes (Vac8[40–515]-tAtg13 and
Vac8[40–515]A51R or L55R-tAtg13 in Figure 4B) and Vac8
[40–515]N62R or N60R,N62R complexed with tNvj1 or tAtg13
(Figure 6C,D), purified protein complexes were loaded onto
a calibrated Superdex 200 10/300 GL column (GE Healthcare
Life Sciences, 17517501) in buffer B, and eluted at a flow rate
of 0.5 mL/min.
Small-angle X-ray scattering
Small-angle X-ray scattering (SAXS) data were collected at
beamline 6D at Pohang Accelerator Laboratory (PAL).
Scattering data were collected using 30 s exposures for each
protein samples (4 mg/mL) in buffer B, followed by back-
ground-subtraction. Further data processing and analysis
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were performed using the ATSAS package [28]. The radius of
gyration (Rg) determined by Guinier analysis was analyzed by
PRIMUS [41], and the distance distribution function P(r) and
maximum dimension of the particle (Dmax) were obtained by
the indirect Fourier transform method using GNOM [42]. Ab
initio modeling of Vac8[40–578]-tNvj1 and Vac8[40–578]-
tAtg13 was performed using DAMMIF [43] with 10 indepen-
dent runs and averaged by DAMAVER [44]. Theoretical
scattering curves were generated by CRYSOL [45] using the
structure of Vac8[Δ19–33]-tNvj1, in which tVac8 coordinates
of the tVac8-tNvj1 were replaced by that of Vac8[Δ19–33],
and Vac8[Δ19–33]-tAtg13 crystal structures. Envelopes gen-
erated by DAMAVER were superimposed with structures
using the SUPCOMB program [46]. Experimental parameters
from SAXS analysis are summarized in Table S3.
Cross-linking
For cross-linking analysis, 0.5 mg/mL wild-type or mutant
Vac8 (Vac8[40–515] or Vac8[40–515]A51R, Vac8[40–515]N62R,
or Vac8[40–515]N60R,N62R) in complex with tAtg13 or tNvj1
was prepared in buffer comprising 25 mM sodium phosphate,
pH 7.5, 150 mM NaCl, 5 mM DTT. Each protein complex was
incubated with 0.001% (w:v) glutaraldehyde (Sigma-Aldrich,
G7651) for 30 min at 20°C. The reaction was stopped by the
addition of 100 mM Tris-HCl, pH 7.6 and reaction products
were analyzed by 8% SDS-PAGE and transferred to
a polyvinylidene difluoride (PVDF) membrane using a Trans-
Blot SD Semi-Dry Transfer Cell (Bio-Rad). The identity of
cross-linked species was analyzed by immunoblotting with
anti-Vac8, anti-Atg13, and anti-Nvj1 antibodies.
Yeast strains and vacuole staining with FM 4-64
Yeast strains used in this study are listed in Table S1. Vacuoles
of growing yeast cells were labeled with FM 4–64 as pre-
viously described [24] with minor modifications. Briefly,
cells were grown at 30°C to an optical density at 600 nm
(OD600) of 0.8 in YPD (10 g/L yeast extract, 20 g/L peptone,
20 g/L dextrose) medium. Cells were then incubated with
aeration in YPD medium containing 20 μM FM 4–64
(Molecular Probes, T13320) for 30 min at 30°C, harvested
by centrifugation (2,400 × g) at room temperature for
1 min, washed, resuspended in fresh medium, and cultured
for a further 3 h at 30°C. After cells were harvested by
centrifugation, they were mounted on a pad of 2% low-
melting agarose formed in a slide and analyzed using
a fluorescence microscope (Nikon Eclipse Ti-U) with
a Nikon Plan Apo 100×, 1.45/NA oil immersion objective.
Cvt and PMN pathway induction
Cells were grown overnight at 30°Cwith shaking in YPDmedium,
cultures were adjusted to OD600 = 0.5, FM 4–64 (0.5 μM) was
added to visualize vacuoles, and cells were further cultured at 30°C
for 2 h. For Cvt pathway induction, cells grown in YPD were
washed with sterile water 3 times, resuspended in nitrogen starva-
tion media (SD-N) (1.7g/L yeast nitrogen base, 20g/L dextrose),
and further cultured at 30°C for 2 h. For PMN induction, 0.2 μM
rapamycin (Sigma-Aldrich, R8781) was added and cells were
further incubated at 30°C for 6 h.
Precursor Ape1 processing assay
Yeast cells were grown overnight at 30°C with shaking in YPD
medium. Cells were washed with sterile water 3 times, resus-
pended in SD-N media, and further cultured at 30°C for 2 h.
Cells were harvested by centrifugation for 10 s at 11,400 × g at
room temperature, and the pellet was resuspended in phos-
phate-buffered saline (PBS; 137 mM NaCl, 2.7 mM KCl,
10 mM Na2HPO4 · 7H20, 1.8 mM KH2PO4). Cells were
vortexed with glass beads for 3 min, mixed with 2× SDS
sample buffer, and boiled for 5 min. After centrifugation,
the resulting supernatant was separated by SDS-PAGE and
analyzed by immunoblotting with anti-Ape1 antiserum (a
generous gift from Dr. Daniel Klionsky, University of
Michigan) or anti-actin antibody (a generous gift from
Dr. Bill Wickner, Dartmouth College).
Phosphopeptide enrichment and LC-MS/MS analysis of Vac8
Protein bands corresponding to Vac8 were excised from the
SDS-PAGE gel and digested in-gel with trypsin for LC-MS/MS
analysis. Enrichment of phosphopeptides was performed as pre-
viously described [47]. Briefly, trypsin-digested proteins were
resuspended in equilibration buffer (50% acetonitrile, 0.1% tri-
fluoroacetic acid) before injection onto the Fe-IMAC column
(Propac IMAC-10 4 × 50 mm, Thermo Scientific, 063276).
Samples were injected (0.1 mL/min over 10 min) onto the Fe-
IMAC column, and the column was washed with equilibration
buffer (0.3 mL/min over 16 min). Phosphopeptides were eluted
with a linear gradient from 0% to 45% Fe-IMAC elution buffer
(0.5%NH4OH; 0.2 mL/min over 60min). The Fe-IMAC column
was re-equilibrated with equilibration buffer (0.5 mL/min over
30 min). Flow-through and eluate fractions were collected
according to the UV signal (214 nm), dried, and stored at −80°
C. LC-MS/MS experiments were performed on anUltimate 3000
nanoHPLC system (Thermo Scientific) coupled online to a Q
Exactive mass spectrometer (Thermo Scientific). Peptides were
injected onto a 20 mm× 75 μmAcclaim PepMap C18 nano-trap
column (Thermo Scientific, 164535) at a flow rate of 300 nL/min
in 98% solvent A (0.1% formic acid in water). After washing,
peptides were separated on a 150 mm × 75 μmAcclaim PepMap
C18 reverse phase analytical column (Thermo Scientific, ES800)
using a linear gradient from 2% to 40% solvent B (acetonitrile
with 0.1% formic acid) over a 65 min gradient with a flow rate of
300 nL/min. Data-dependent scans consisting of one full MS
scan (450–2,000 m/z, AGC target 1e6) and 10 data-dependent
MS/MS scans were used to generate MS/MS spectra of eluted
peptides using the dynamic exclusion option.
Mass spectrometric data analysis
Mass spectrometry-derived data were searched against the cano-
nical S. cerevisiae proteome database downloaded from
UniProtKB (http://www.uniprot.org/) using Proteome
Discoverer software (Thermo Scientiﬁc). Mass spectrometry
data were searched using the SEQUEST algorithm with
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carbamidomethylation of cysteine as a ﬁxed modiﬁcation, and
N-terminal acetylation, oxidation of methionine and phosphor-
ylation at serine, threonine, and tyrosine as variable modiﬁca-
tions. MS/MS spectra were searched with a precursor mass
tolerance of 10 ppm and fragment mass tolerance of 0.02 Da.
The search was limited to fully tryptic peptide candidates and
a maximum of 2 missed cleavages were allowed. Data were
searched against the target-decoy database and peptide spectral
matches (PSM) were validated using percolator based on
q-values at a 1% false discovery rate (FDR).
Immunoblotting
Samples were separated by SDS-PAGE and analyzed by immuno-
blotting with indicated antibodies. ECL exposed films were quan-
titated using ImageJ software. All data are representative of
experiments performed at least 3 times. Actin levels were analyzed
and confirmed comparable between samples by comparing band
intensities of actin from increasing concentrations of yeast cytosol.
Statistical analysis
Statistical significance was determined from at least 3 inde-
pendent experiments using Student’s t-test. All data represent
the mean ± SEM.
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